Pharmacology Unit, School of Medicine, Western Sydney University, Campbelltown, NSW 2560, Australia.
NICM Health Research Institute, Western Sydney University, Westmead, NSW 2145, Australia.
Int J Mol Sci. 2023 Apr 6;24(7):6850. doi: 10.3390/ijms24076850.
Identification of bioactive natural products from plants starts with the screening of extracts for a desired bioactivity such as antimicrobial, antifungal, anti-cancer, anti-inflammatory, or neuroprotective. When the bioactivity shows sufficient potency, the plant material is subjected to bio-activity-guided fractionation, which involves, e.g., sequential extraction followed by chromatographic separation, including HPLC. The bioactive compounds are then structurally identified by high-resolution mass spectrometry and nuclear magnetic resonance (NMR). One of the questions that come up during the purification process is how much of the bioactivity originally present in the crude extract is preserved during the purification process. If this is the case, it is interesting to investigate if the loss of total bioactivity is caused by the loss of material during purification or by the degradation or evaporation of potent compounds. A further possibility would be the loss of synergy between compounds present in the mixture, which disappears when the compounds are separated. In this publication, a novel formula is introduced that allows researchers to calculate total bioactivity in biological samples using experimental data from our research into the discovery of anti-inflammatory compounds from (Grey Myrtle). The results presented show that a raw ethanolic extract retains slightly more bioactivity than the sum of all sequential extracts per gram of starting material and that-despite a large loss of material during HPLC purification-the total bioactivity in all purified fractions is retained, which is indicative of rather an additive than a synergistic principle.
从植物中鉴定具有生物活性的天然产物首先要筛选具有所需生物活性的提取物,如抗菌、抗真菌、抗癌、抗炎或神经保护活性。当生物活性显示出足够的效力时,植物材料将进行基于生物活性的分离,例如,顺序提取后进行色谱分离,包括 HPLC。然后通过高分辨率质谱和核磁共振(NMR)对生物活性化合物进行结构鉴定。在纯化过程中出现的一个问题是,在纯化过程中原始粗提物中存在的生物活性有多少得以保留。如果是这样,那么研究在纯化过程中总生物活性损失是由于材料损失还是由于有效化合物的降解或蒸发引起的就很有趣。另一种可能性是混合物中存在的化合物之间协同作用的丧失,当化合物分离时,这种协同作用就会消失。在本出版物中,引入了一种新的公式,允许研究人员使用我们对从(灰桃金娘)中发现抗炎化合物的研究中的实验数据来计算生物样品中的总生物活性。所呈现的结果表明,与起始材料每克的所有顺序提取物的总和相比,原始乙醇提取物保留了略多的生物活性,并且尽管在 HPLC 纯化过程中大量损失了材料,但所有纯化馏分中的总生物活性得以保留,这表明是加性原则而不是协同性原则。